 | This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about FOLFOXIRI.
|
Numerous Frontline CRC Options Allow Individualized Approach. April 2016 clinical trial results with VEGFR and EGFR inhibitors. - Rod57 ( talk) 13:12, 27 April 2016 (UTC)
|
| This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
|
| Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about FOLFOXIRI.
|
Numerous Frontline CRC Options Allow Individualized Approach. April 2016 clinical trial results with VEGFR and EGFR inhibitors. - Rod57 ( talk) 13:12, 27 April 2016 (UTC)